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Introduction / objectives
Since 2007, the Netherlands is facing a large ongoing Q-
fever outbreak with > 4000 cases of acute Q-fever
reported. Q-fever is a zoonotic disease with (almost)
only animal-to-human transmission. Pregnant women
with Q-fever develop placentitis with highly infectious
birth-products which may result in human-to-human
transmission during delivery. In the absence of guide-
lines, a Q-fever protocol was developed and prospec-
tively evaluated.
Methods
All pregnant women with Q-fever were included.Â All
were treated with antibiotics. During delivery strict iso-
lation measures were taken. After delivery the room was
cleaned, ventilated and strict isolation ended. A combi-
nation of contact- and droplet-isolation during personal
hygiene of the mother was continued as lochia may still
be infectious.
Results
In total 11 women were identified. All gave birth to
healthy babies. Q-fever PCR on birth-products and
umbilical blood were negative except for one case who
received inadequate antimicrobial treatment. All babies
had maternal antibodies which disappeared over time.
Breast milk was found PCR negative; therefore breast-
feeding was allowed. No human-to-human transmission
(no clinical cases of Q-fever) occurred during these
deliveries.
Conclusion
While the combination of antibiotic treatment and strict
isolation measures during delivery was effective in pre-
venting human-to-human transmission in our cohort,
the psychological burden of the measures for the
patients and their family was extremely high. Effective
antibiotic treatment seems to eliminate the bacterial
load of human birth products, but isolation measures
should be continued until our findings are confirmed in
a higher number of cases.
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